限制性股票激励

Search documents
合康新能: 北京市嘉源律师事务所关于北京合康新能科技股份有限公司2023年限制性股票激励计划首次授予部分第一个归属期归属条件成就及部分限制性股票作废事项的法律意见书
Zheng Quan Zhi Xing· 2025-07-04 16:13
Core Viewpoint - The legal opinion letter from Beijing Jiayuan Law Firm confirms the compliance and authorization of Beijing Hekang New Energy Technology Co., Ltd.'s 2023 restricted stock incentive plan, including the achievement of conditions for the first vesting period and the cancellation of certain unvested restricted stocks [1][4][5]. Group 1: Legal Compliance and Authorization - The law firm conducted a thorough review of the relevant documents and confirmed that the company provided all necessary materials for the legal opinion [2][4]. - The company has fulfilled the required procedures for the approval of the vesting and cancellation of restricted stocks, including resolutions passed by the board of directors [4][5]. Group 2: Vesting Conditions and Achievements - The first vesting period for the restricted stocks starts from the first grant date, September 8, 2023, and lasts until the last trading day within 28 months [5]. - The conditions for the first vesting period have been met, including no negative audit opinions on financial reports and compliance with internal control requirements [5][7]. Group 3: Performance Targets and Metrics - The performance targets for the incentive plan include a revenue increase of no less than 110% and a net profit increase of no less than 205% compared to 2022 for the first vesting period [8][9]. - The vesting ratio is determined based on the achievement of performance targets, with a scale from 0% to 100% depending on the actual performance [9]. Group 4: Cancellation of Restricted Stocks - The company confirmed the cancellation of 1,280,000 unvested restricted stocks due to the departure of certain incentive plan participants, which aligns with the plan's regulations [9][10]. - The cancellation of these stocks is deemed compliant with relevant laws and regulations [10].
伟测科技: 监事会关于公司2025年限制性股票激励计划激励对象名单的公示情况说明及核查意见
Zheng Quan Zhi Xing· 2025-07-04 16:12
Core Points - The company has announced the public disclosure and verification of the list of incentive objects for its 2025 restricted stock incentive plan [1][2] - The supervisory board confirmed that no objections were raised during the public disclosure period, which lasted from June 25 to July 4, 2025 [2] - The supervisory board conducted a thorough verification of the proposed incentive objects, ensuring compliance with relevant laws and regulations [2][5] Disclosure and Verification Process - The company publicly disclosed the names and positions of the proposed incentive objects internally for a period of 10 days [1] - Employees were allowed to provide feedback through verbal or written means during the public disclosure period [1][2] Supervisory Board's Verification Opinion - The supervisory board reviewed the list of incentive objects and confirmed that all individuals met the qualifications set forth in the relevant laws and regulations [2][5] - The verification process included checking the identity documents, employment contracts, and positions held by the proposed incentive objects [2] - The supervisory board concluded that all individuals listed as incentive objects are legally and validly qualified under the incentive plan [5]
聚灿光电: 关于向2025年限制性股票激励计划激励对象首次授予限制性股票的公告
Zheng Quan Zhi Xing· 2025-07-03 16:27
Core Points - The company has announced the first grant of restricted stock under the 2025 Restricted Stock Incentive Plan, with a grant date of July 3, 2025, and a total of 8.045 million shares to be granted at a price of 5.68 yuan per share [1][13][17] Summary by Sections Incentive Plan Overview - The 2025 Restricted Stock Incentive Plan includes 252 eligible participants, primarily senior management and core employees, excluding independent directors and major shareholders [1][19] - The total number of shares granted is 8.045 million, representing 80.45% of the total plan allocation [1][12] Grant Conditions and Approval - The grant conditions have been met, and the plan has received necessary approvals from the board and shareholders [11][20] - The plan's effective period lasts until all granted shares are vested or become void, not exceeding 60 months [2] Vesting Schedule - The vesting of the restricted stock will occur in three phases based on performance metrics tied to revenue growth targets for the years 2025 to 2027 [3][5] - Specific performance targets include a 34% revenue growth for 2025, 40% for 2026, and 46% for 2027, with vesting contingent on achieving at least 90% of these targets [4][6] Financial Impact - The fair value of the restricted stock will be calculated using the Black-Scholes model, and the associated costs will be recognized in the company's financial statements over the vesting period [14][15] - The incentive plan is expected to positively influence the company's performance by enhancing management motivation and operational efficiency [15] Compliance and Legal Opinions - Legal and financial advisors have confirmed that the incentive plan complies with relevant laws and regulations, and all necessary disclosures have been made [20][18]
实朴检测: 关于公司2023年限制性股票激励计划第二个归属期归属结果暨股份上市公告
Zheng Quan Zhi Xing· 2025-07-03 16:27
Summary of Key Points Core Viewpoint The announcement details the completion of the second vesting period for the 2023 Restricted Stock Incentive Plan of Shibao Testing Technology (Shanghai) Co., Ltd., including the approval process, vesting conditions, and the number of shares vested. Group 1: Incentive Plan Overview - The company approved the second vesting conditions of the 2023 Restricted Stock Incentive Plan during board and shareholder meetings held in May and June 2025 [1][2][3] - The total number of restricted shares granted was 300,000, which represents 2.50% of the company's total share capital at the time of the plan announcement [3][4] Group 2: Vesting Conditions and Performance Targets - The vesting schedule includes three periods, with the second vesting period allowing for 30% of the shares to vest after 24 months from the grant date [5][6] - The performance targets for the first three years include a net profit growth rate of 150% for 2023, 50% for 2024, and 50% for 2025, with specific trigger values for each year [7][8] Group 3: Approval Process and Compliance - The independent directors provided opinions on the incentive plan's benefits for the company's sustainable development, and the plan was publicly disclosed without objections during the review period [11][12] - The company has complied with all necessary legal and regulatory requirements for the incentive plan, including obtaining the required approvals from the board and shareholders [20][21] Group 4: Share Vesting and Impact - A total of 575,445 shares were vested to 25 individuals, with the vesting price set at 8.38 yuan per share [20][21] - The shares are sourced from the company's repurchase from the secondary market, ensuring that the total share capital remains unchanged [22][23] Group 5: Future Implications - The company plans to use the funds raised from the share vesting to supplement its working capital, and the vesting will not significantly impact the company's financial status or shareholder structure [23][24]
诺泰生物: 诺泰生物:关于2023年限制性股票激励计划第二个归属期归属结果暨股份上市公告
Zheng Quan Zhi Xing· 2025-07-03 16:27
Core Viewpoint - The announcement details the implementation of the 2023 Restricted Stock Incentive Plan by Jiangsu Nuotai Aosaino Biopharmaceutical Co., Ltd, including the allocation of restricted stocks and their upcoming listing date. Group 1: Stock Listing and Allocation - The total number of stocks to be listed for circulation is 1,232,616 shares, with the listing date set for July 9, 2025 [1][7]. - The stock allocation includes 62 incentive recipients, with a total of 410.8720 million shares granted, representing 30% of the total granted shares [5][6]. Group 2: Decision-Making Process - The decision-making process for the stock allocation involved multiple meetings, including the approval of the incentive plan by the board and independent directors, as well as the verification of the incentive recipient list by the supervisory board [2][3][4]. Group 3: Financial Impact - Following the stock allocation, the total share capital will increase from 314,819,281 shares to 316,051,897 shares, with the new shares accounting for approximately 0.39% of the total share capital [10][11]. - The basic earnings per share (EPS) for 2024 will be diluted, calculated based on the new total share capital, while the net profit attributable to shareholders remains unchanged at 404,389,990.70 yuan [11].
龙磁科技: 关于2023年限制性股票激励计划第二个解除限售期解除限售股份上市流通的提示性的公告
Zheng Quan Zhi Xing· 2025-07-03 16:26
Core Points - The company announced the lifting of restrictions on 437,458 shares of restricted stock on July 8, 2025, which represents 0.3665% of the total share capital [1][14] - A total of 86 individuals are eligible for the lifting of restrictions under the 2023 Restricted Stock Incentive Plan [1][14] - The second lifting of restrictions is based on the fulfillment of specific performance conditions outlined in the incentive plan [6][9] Summary by Sections Incentive Plan Approval and Conditions - The board of directors and the supervisory board approved the lifting of restrictions on the second phase of the 2023 Restricted Stock Incentive Plan during meetings held on July 1, 2025 [1][2] - The plan's second lifting period lasts from the completion of the stock grant registration for 24 months, with the lifting conditions needing to be met [6][9] Performance Metrics - The performance metrics for the lifting of restrictions include revenue growth and net profit growth, with specific targets set based on the company's 2022 financial performance [8][10] - The company achieved a revenue of approximately 1.17 billion yuan and a net profit of approximately 111 million yuan for the year 2024, meeting the required performance conditions [8][10] Changes in Incentive Plan Participants - The number of eligible participants in the incentive plan was adjusted from 92 to 91 due to one participant voluntarily opting out [11][12] - The stock grant price was adjusted from 17.67 yuan to 17.47 yuan per share following the company's 2022 equity distribution [11][12] Stock Buyback and Cancellation - The company has conducted buybacks and cancellations of restricted stocks due to participants leaving the company or not meeting performance targets, resulting in a reduction of eligible shares [12][14] - A total of 739,096 shares were repurchased and canceled due to performance not meeting the set targets for the first lifting period [12][14]
韶能股份: 广东韶能集团股份有限公司第十一届监事会第七次临时会议决议公告
Zheng Quan Zhi Xing· 2025-07-03 16:26
Core Viewpoint - The company, Guangdong Shaoneng Group Co., Ltd., has convened its 11th Supervisory Board's 7th temporary meeting to approve the proposal for issuing A-shares to specific investors, which requires further approval from the shareholders' meeting [1][2]. Meeting Details - The meeting was held on July 3, 2025, with all four supervisors present, including one via telecommunication [1]. - The meeting's procedures complied with legal and regulatory requirements, ensuring the resolutions made were valid [1]. Resolutions Passed - The Supervisory Board approved the proposal regarding the company's eligibility to issue A-shares to specific investors, confirming compliance with relevant laws and regulations [2]. - The specific issuance plan was also approved, with the shares to be issued at a price of 3.96 yuan per share, which is not less than 80% of the average trading price over the previous 20 trading days [4]. - The total amount to be raised from this issuance is capped at 400 million yuan, with net proceeds intended for replenishing working capital [5]. Issuance Details - The issuance will involve a maximum of 101,010,101 shares, not exceeding 30% of the company's total share capital prior to the issuance [5]. - The shares will be subscribed for in cash by Shaoguan Jin Cai Investment Group Co., Ltd., which is the sole designated investor [3][4]. Additional Proposals - The board also approved a feasibility analysis report regarding the use of funds raised from the issuance [10]. - A plan for shareholder returns for the next three years (2025-2027) was established to enhance transparency and protect investor interests [14]. - The company plans to amend its articles of association to reflect changes in governance, including the cancellation of the Supervisory Board [14]. Future Steps - All resolutions passed are subject to approval at the upcoming shareholders' meeting [2][9]. - The company will submit the issuance plan to the Shenzhen Stock Exchange and await approval from the China Securities Regulatory Commission [8].
美农生物: 关于召开2025年第一次临时股东会的通知
Zheng Quan Zhi Xing· 2025-07-03 16:26
Meeting Information - The company will hold its first extraordinary general meeting of shareholders in 2025 on July 22, 2025, at 14:30 [1] - The meeting will include both on-site voting and online voting options [2] - Online voting will be available through the Shenzhen Stock Exchange trading system and internet voting system on the same day [2] Voting Procedures - Shareholders can attend the meeting in person or authorize a representative to attend [2] - Voting rights can be exercised either through on-site or online voting, but not both for the same proposal [2][3] - The voting results will be based on the first valid vote in case of duplicate voting [2][3] Agenda Items - The meeting will discuss several proposals, including the "2025 Restricted Stock Incentive Plan (Draft)" and its management measures [3] - These proposals require a two-thirds majority approval from the attending shareholders [3][4] Registration Details - Shareholders must register to attend the meeting, with specific requirements for both corporate and individual shareholders [4][5] - Registration can also be done via mail or fax for remote shareholders, but must be completed by July 21, 2025 [5] Contact Information - For inquiries, shareholders can contact the company via phone, fax, or email [5][6]
鹏鼎控股: 鹏鼎控股(深圳)股份有限公司关于2021年限制性股票激励计划第四个解除限售期解除限售股份上市流通的提示性公告
Zheng Quan Zhi Xing· 2025-07-03 16:15
证券代码:002938 证券简称:鹏鼎控股 公告编号:2025-043 鹏鼎控股(深圳)股份有限公司 关于 2021 年限制性股票激励计划第四个解除限售期 解除限售股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 特别提示: 票数量 133.68 万股,占公司目前总股本的 0.0577%。 鹏鼎控股(深圳)股份有限公司(以下简称"公司") 于 2025 年 4 月 8 日召开了第三届董事会第十五次会议及第三届监事会第十一次会议,审议通过了 《关于公司 2021 年限制性股票激励计划第四个解除限售期解除限售条件部分成 就的议案》(具体详见公司于 2025 年 4 月 9 日披露在《证券时报》、《上海证 券报》和巨潮资讯网(www.cninfo.com.cn)的鹏鼎控股《关于公司 2021 年限制 性股票激励计划第四个解除限售期解除限售条件部分成就的公告》(公告编号: 划")第四个解除限售期解除限售条件部分成就,根据公司 2020 年年度股东大 会的授权,公司按照规定为本次符合解除限售条件的激励对象办理第四个解除限 售期解除限售相关事宜。现 ...
通用股份: 江苏通用科技股份有限公司关于2023年部分限制性股票回购注销实施公告
Zheng Quan Zhi Xing· 2025-07-03 16:15
Core Points - The company plans to repurchase and cancel 175,000 restricted shares due to 10 incentive recipients not meeting the 100% release conditions from the 2023 incentive plan [1][2] - The decision was approved during the board and supervisory meetings held on April 28, 2025 [1][2] - The repurchase is in accordance with the relevant laws and regulations, including the "Management Measures for Equity Incentives of Listed Companies" [2][5] Repurchase and Cancellation Details - The repurchase involves 10 incentive recipients, with performance evaluations resulting in 4 individuals rated B and 6 rated C, thus not qualifying for full release [2] - The repurchase will be processed through a dedicated securities account at China Securities Depository and Clearing Corporation [2] - The cancellation of shares is expected to be completed by July 8, 2025, followed by necessary business registration changes [3] Share Structure Changes - The share structure will change as follows: - Restricted shares before: 12,630,000; after cancellation: 12,455,000 - Unrestricted shares remain at 1,576,860,735 - Total shares before: 1,589,490,735; after cancellation: 1,589,315,735 [4] Compliance and Legal Opinions - The board confirms that the decision-making process and information disclosure comply with legal requirements and do not harm the rights of incentive recipients or creditors [5] - Legal opinions affirm that the repurchase and cancellation are in line with applicable laws and regulations, ensuring no significant harm to the company or shareholders [5][6]